Genetic testing cost effective for newly diagnosed GIST

(University of California - San Diego) UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.